Alnylam Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: ALNY
Share price (10/7/26): $224.41
Market cap (10/7/26): $30.0 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Greenstreet Yvonne

Pyott David E I

Cravatt Benjamin

News Filter

Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress

Change in Directors, Officers or Compensation, Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress

Change in Directors, Officers or Compensation

Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission